All News Bright Minds Biosciences Inc.

Equities

DRUG

CA10919W4056

Market Closed - Canadian Securities Exchange Other stock markets 09:18:37 16/05/2024 pm IST			5-day change	1st Jan Change
1.43 ^CAD	0.00%		+4.38%	-32.55%

16/05	Bright Minds Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
22/03	Bright Minds Biosciences Inc. announced that it expects to receive $0.05416 million in funding	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bright Minds Biosciences : Condensed Interim Consolidated Financial Statements For the six months ended March 31, 2024 and 2023 (Expressed in Canadian Dollars) - Form 6-K	17/05	PU
Bright Minds Biosciences : Notice of Meeting and Record Date - Form 6-K	17/05	PU
Bright Minds Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	16/05	CI
Bright Minds Biosciences Inc. announced that it expects to receive $0.05416 million in funding	22/03	CI
Bright Minds Biosciences Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02	CI
Bright Minds Biosciences Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	30/12	CI
Bright Minds Biosciences : Announces Closing of Non-Brokered Private Placement Fully Subscribed by Management - Form 6-K	26/12	PU
Bright Minds Biosciences Inc. announced that it has received $0.9 million in funding	22/12	CI
Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management	07/12	AQ
Bright Minds Biosciences Inc. announced that it expects to receive $0.9 million in funding	06/12	CI
Bright Minds Biosciences : Condensed Interim Consolidated Financial Statements For the three and nine months ended June 30, 2023 and 2022 (Expressed in Canadian Dollars) - Form 6-K	15/23/15	PU
Bright Minds Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	15/23/15	CI
Top Midday Gainers	08/23/08	MT
Bright Minds Biosciences on "Positive" qEEG Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101	08/23/08	MT
Bright Minds Biosciences Brief: Announcing "Positive" qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101	08/23/08	MT
Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101	08/23/08	AQ
Bright Minds Biosciences Inc. Announces Positive qEEG (Quantitative Electroencephalogram) Data from Its First-In-Human Phase 1 Study of Lead Compound, Bmb-101	08/23/08	CI
Bright Minds Biosciences : Announces Positive qEEG (Quantitative Electroencephalogram) Data fromits First-in-Human Phase 1 Study of Lead Compound, BMB-101	07/23/07	PU
Bright Minds Biosciences Announced "Positive" Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101	20/23/20	MT
Bright Minds Biosciences Inc. Announces Successful Completion of its Three-Part Phase 1 Study of BMB-101	20/23/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Bright Minds Biosciences Inc.

Equities

DRUG

CA10919W4056

All News

Filters